{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:18:27Z","timestamp":1793085507643,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-03893-7","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:20:27Z","timestamp":1738110027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET\/CT"],"prefix":"10.1186","volume":"23","author":[{"given":"Chong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"3893_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/ejh.13271","volume":"103","author":"R Dada","year":"2019","unstructured":"Dada R. Diagnosis and management of follicular lymphoma: a comprehensive review. Eur J Haematol. 2019;103:152\u201363.","journal-title":"Eur J Haematol"},{"key":"3893_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3960\/jslrt.22046","volume":"63","author":"AM Maeshima","year":"2023","unstructured":"Maeshima AM. Histologic transformation of follicular lymphoma: pathologists\u2019 viewpoint. J Clin Exp Hematop. 2023;63:12\u20138.","journal-title":"J Clin Exp Hematop"},{"key":"3893_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00277-017-3151-2","volume":"97","author":"T Fischer","year":"2018","unstructured":"Fischer T, Zing NPC, Chiattone CS, Federico M, Luminari S. Transformed follicular lymphoma. Ann Hematol. 2018;97:17\u201329.","journal-title":"Ann Hematol"},{"key":"3893_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17474086.2017.1326812","volume":"10","author":"M Mendez","year":"2017","unstructured":"Mendez M, Torrente M, Provencio M. Follicular lymphomas and their transformation: past and current research. Expert Rev Hematol. 2017;10:515\u201324.","journal-title":"Expert Rev Hematol"},{"key":"3893_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/asheducation-2015.1.625","volume":"2015","author":"S Montoto","year":"2015","unstructured":"Montoto S. Treatment of patients with transformed lymphoma. Hematology Am Soc Hematol Educ Program. 2015;2015:625\u201330.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3893_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","volume":"125","author":"C Casulo","year":"2015","unstructured":"Casulo C, Burack WR, Friedberg JW. Transformed follicular non-Hodgkin lymphoma. Blood. 2015;125:40\u20137.","journal-title":"Blood"},{"key":"3893_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/annonc\/mdl014","volume":"17","author":"S W\u00f6hrer","year":"2006","unstructured":"W\u00f6hrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A, Turetschek K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol. 2006;17:780\u20134.","journal-title":"Ann Oncol"},{"key":"3893_CR8","first-page":"202","volume":"41","author":"A D\u00edaz-Silv\u00e1n","year":"2022","unstructured":"D\u00edaz-Silv\u00e1n A, Ot\u00f3n-S\u00e1nchez LF, Caresia-Ar\u00f3ztegui AP, Del Puig C-S, Orcajo-Rinc\u00f3n J, de Arcocha-Torres M, et al. Clinical application of (18F)FDG PET\/CT in follicular lymphoma. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022;41:202\u201312.","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"3893_CR9","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Sch\u00f6der","year":"2005","unstructured":"Sch\u00f6der H, Noy A, G\u00f6nen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23:4643\u201351.","journal-title":"J Clin Oncol"},{"key":"3893_CR10","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","volume":"20","author":"JYY Ngeow","year":"2009","unstructured":"Ngeow JYY, Quek RHH, Ng DCE, Hee SW, Tao M, Lim LC, et al. High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma. Ann Oncol. 2009;20:1543\u20137.","journal-title":"Ann Oncol"},{"key":"3893_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","volume":"20","author":"A Noy","year":"2009","unstructured":"Noy A, Sch\u00f6der H, G\u00f6nen M, Weissler M, Ertelt K, Cohler C, et al. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol. 2009;20:508\u201312.","journal-title":"Ann Oncol"},{"key":"3893_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3324\/haematol.12013","volume":"93","author":"C Bodet-Milin","year":"2008","unstructured":"Bodet-Milin C, Kraeber-Bod\u00e9r\u00e9 F, Moreau P, Campion L, Dupas B, Le Gouill S. Investigation of FDG-PET\/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica. 2008;93:471\u20132.","journal-title":"Haematologica"},{"key":"3893_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2967\/jnumed.114.149625","volume":"56","author":"MJ Wondergem","year":"2015","unstructured":"Wondergem MJ, Rizvi SN, Jauw Y, Hoekstra OS, Hoetjes N, van de Ven PM, et al. 18F-FDG or 3\u2019-deoxy-3\u2019-18F-fluorothymidine to detect transformation of follicular lymphoma. J Nucl Med. 2015;56:216\u201321.","journal-title":"J Nucl Med"},{"key":"3893_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/pcmedi\/pbab026","volume":"4","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gu J, Zhu Y, Meng Z, Tong T, Li D, et al. AI in spotting high-risk characteristics of medical imaging and molecular pathology. Precis Clin Med. 2021;4:271\u201386.","journal-title":"Precis Clin Med"},{"key":"3893_CR15","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1007\/s00330-019-06291-9","volume":"29","author":"CP Reinert","year":"2019","unstructured":"Reinert CP, Federmann B, Hofmann J, B\u00f6sm\u00fcller H, Wirths S, Fritz J, et al. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome. Eur Radiol. 2019;29:6911\u201321.","journal-title":"Eur Radiol"},{"issue":"2","key":"3893_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/medicina60020203","volume":"60","author":"D Albano","year":"2024","unstructured":"Albano D, Calabr\u00f2 A, Dondi F, Bertagna F. 2-[18F]-FDG PET\/CT Semiquantitative and radiomics predictive parameters of Richter\u2019s transformation in CLL patients. Medicina (Kaunas). 2024;60(2):203.","journal-title":"Medicina (Kaunas)"},{"key":"3893_CR17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00259-021-05626-3","volume":"49","author":"FM de Jesus","year":"2022","unstructured":"de Jesus FM, Yin Y, Mantzorou-Kyriaki E, Kahle XU, de Haas RJ, Yakar D, et al. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic (18F)FDG PET\/CT features. Eur J Nucl Med Mol Imaging. 2022;49:1535\u201343.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3893_CR18","doi-asserted-by":"publisher","first-page":"e230255","DOI":"10.1148\/radiol.230255","volume":"308","author":"M Li","year":"2023","unstructured":"Li M, Fan Y, You H, Li C, Luo M, Zhou J, et al. Dual-energy CT deep learning radiomics to predict macrotrabecular-massive hepatocellular carcinoma. Radiology. 2023;308:e230255.","journal-title":"Radiology"},{"key":"3893_CR19","doi-asserted-by":"publisher","first-page":"e002118","DOI":"10.1136\/jitc-2020-002118","volume":"9","author":"W Mu","year":"2021","unstructured":"Mu W, Jiang L, Shi Y, Tunali I, Gray JE, Katsoulakis E, et al. Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET\/CT images. J Immunother Cancer. 2021;9:e002118.","journal-title":"J Immunother Cancer"},{"key":"3893_CR20","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1007\/s00330-020-07544-8","volume":"31","author":"M Jiang","year":"2021","unstructured":"Jiang M, Zhang D, Tang SC, Luo XM, Chuan ZR, Lv WZ, et al. Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study. Eur Radiol. 2021;31:3673\u201382.","journal-title":"Eur Radiol"},{"key":"3893_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"3893_CR22","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786\u20139.","journal-title":"Cancer Res"},{"key":"3893_CR23","doi-asserted-by":"crossref","unstructured":"Xu H, Liang P, Yu W, Jiang J, Ma J. Learning a generative model for fusing infrared and visible images via conditional generative adversarial network with dual discriminators. In: Proceedings of the Twenty-Eighth International Joint Conference on Artificial Intelligence (IJCAI-19). 2019:3954\u20133960.","DOI":"10.24963\/ijcai.2019\/549"},{"issue":"1","key":"3893_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2967\/jnumed.120.242412","volume":"62","author":"N Capobianco","year":"2021","unstructured":"Capobianco N, Meignan M, Cottereau AS, Vercellino L, Sibille L, Spottiswoode B, et al. Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma. J Nucl Med. 2021;62(1):30\u20136.","journal-title":"J Nucl Med"},{"issue":"4","key":"3893_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s10278-020-00341-1","volume":"33","author":"S Jemaa","year":"2020","unstructured":"Jemaa S, Fredrickson J, Carano RAD, Nielsen T, de Crespigny A, Bengtsson T. Tumor segmentation and feature extraction from whole-body FDG-PET\/CT using cascaded 2D and 3D convolutional neural networks. J Digit Imaging. 2020;33(4):888\u201394.","journal-title":"J Digit Imaging"},{"issue":"1","key":"3893_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40644-022-00476-0","volume":"22","author":"S Jemaa","year":"2022","unstructured":"Jemaa S, Paulson JN, Hutchings M, Kostakoglu L, Trotman J, Tracy S, et al. Full automation of total metabolic tumor volume from FDG-PET\/CT in DLBCL for baseline risk assessments. Cancer Imaging. 2022;22(1):39.","journal-title":"Cancer Imaging"},{"issue":"1","key":"3893_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","volume":"122","author":"AB Khan","year":"2013","unstructured":"Khan AB, Barrington SF, Mikhaeel NG, Hunt AA, Cameron L, Morris T, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood. 2013;122(1):61\u20137.","journal-title":"Blood"},{"issue":"10","key":"3893_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2967\/jnumed.113.134486","volume":"55","author":"JJ Cerci","year":"2014","unstructured":"Cerci JJ, Gy\u00f6rke T, Fanti S, Paez D, Meneghetti JC, Redondo F, et al. Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphoma. J Nucl Med. 2014;55(10):1591\u20137.","journal-title":"J Nucl Med"},{"issue":"5","key":"3893_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00259-017-3899-6","volume":"45","author":"N Aide","year":"2018","unstructured":"Aide N, Talbot M, Fruchart C, Damaj G, Lasnon C. Diagnostic and prognostic value of baseline FDG PET\/CT skeletal textural features in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018;45(5):699\u2013711.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"3893_CR30","doi-asserted-by":"publisher","first-page":"23812","DOI":"10.1038\/s41598-021-03278-9","volume":"11","author":"J Faudemer","year":"2021","unstructured":"Faudemer J, Aide N, Gac AC, Damaj G, Vilque JP, Lasnon C. Diagnostic value of baseline 18FDG PET\/CT skeletal textural features in follicular lymphoma. Sci Rep. 2021;11(1):23812.","journal-title":"Sci Rep"},{"key":"3893_CR31","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1002\/mp.13678","volume":"47","author":"M Avanzo","year":"2020","unstructured":"Avanzo M, Wei L, Stancanello J, Valli\u00e8res M, Rao A, Morin O, et al. Machine and deep learning methods for radiomics. Med Phys. 2020;47:e185\u2013202.","journal-title":"Med Phys"},{"issue":"47","key":"3893_CR32","doi-asserted-by":"publisher","first-page":"e8705","DOI":"10.1097\/MD.0000000000008705","volume":"96","author":"S P\u00e9ricart","year":"2017","unstructured":"P\u00e9ricart S, Martin-Blondel G, Franchet C, Hitzel A, Brousset P. 18F-fluorodeoxyglucose positron emission tomography computed tomography detection threshold in follicular lymphoma: a case report. Medicine (Baltimore). 2017;96(47):e8705.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3893_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-023-00525-1","volume":"11","author":"JL Vaughn","year":"2023","unstructured":"Vaughn JL, Epperla N. Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort study. Biomark Res. 2023;11(1):84.","journal-title":"Biomark Res"},{"key":"3893_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.inffus.2021.06.001","volume":"76","author":"Xu Han","year":"2021","unstructured":"Han Xu, Ma J. EMFusion: an unsupervised enhanced medical image fusion network. Information Fusion. 2021;76:177\u201386.","journal-title":"Information Fusion"},{"key":"3893_CR35","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1109\/TIP.2020.2977573","volume":"29","author":"J Ma","year":"2020","unstructured":"Ma J, Han Xu, Jiang J, Mei X, Zhang XP. DDcGAN: a dual-discriminator conditional generative adversarial network for multi-resolution image fusion. IEEE Transactions on Image Processing. 2020;29:4980\u201395.","journal-title":"IEEE Transactions on Image Processing"},{"key":"3893_CR36","doi-asserted-by":"publisher","first-page":"55145","DOI":"10.1109\/ACCESS.2020.2982016","volume":"8","author":"J Huang","year":"2020","unstructured":"Huang J, Le Z, Ma Y, Fan F, Zhang H, Yang L. MGMDcGAN: medical image fusion using multi-generator multi-discriminator conditional generative adversarial network. IEEE Access. 2020;8:55145\u201357.","journal-title":"IEEE Access"},{"key":"3893_CR37","doi-asserted-by":"crossref","unstructured":"Liu Y, Chen X, Cheng J, Peng H. A medical image fusion method based on convolutional neural networks. In: Proc. 20th International Conference on Information Fusion (Fusion). Xi'an: Conference; 2017. p. 1\u20137.","DOI":"10.23919\/ICIF.2017.8009769"},{"key":"3893_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.inffus.2019.07.011","volume":"54","author":"Yu Yu Zhang","year":"2020","unstructured":"Yu Zhang Yu, Liu PS, Yan H, Zhao X, Zhang Li. IFCNN: a general image fusion framework based on convolutional neural network. Information Fusion. 2020;54:99\u2013118.","journal-title":"Information Fusion"},{"key":"3893_CR39","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1109\/TIP.2020.3043125","volume":"30","author":"R Liu","year":"2020","unstructured":"Liu R, Liu J, Jiang Z, Fan X, Luo Z. A bilevel integrated model with data-driven layer ensemble for multi-modality image fusion. IEEE Trans Image Process. 2020;30:1261\u201374.","journal-title":"IEEE Trans Image Process"},{"key":"3893_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nhres.2021.07.002","volume":"1","author":"W Qi","year":"2021","unstructured":"Qi W, Chong Xu, Xiwei Xu. AutoGluon: a revolutionary framework for landslide hazard analysis. Natural Hazards Research. 2021;1:103\u20138.","journal-title":"Natural Hazards Research"},{"key":"3893_CR41","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1080\/10428194.2020.1779254","volume":"61","author":"C Madsen","year":"2020","unstructured":"Madsen C, Plesner TL, Bentzen HH, J\u00f8rgensen J, Sillesen IB, Himmelstrup BM, et al. Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leuk Lymphoma. 2020;61:2584\u201394.","journal-title":"Leuk Lymphoma"},{"key":"3893_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clml.2022.09.003","volume":"23","author":"C Casulo","year":"2023","unstructured":"Casulo C, Herold M, Hiddemann W, Iyengar S, Marcus RE, Seymour JF, et al. Risk factors for and outcomes of follicular lymphoma histological transformation at first progression in the GALLIUM study. Clin Lymphoma Myeloma Leuk. 2023;23:40\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3893_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hon.2601","volume":"37","author":"M M\u00e9ndez","year":"2019","unstructured":"M\u00e9ndez M, Torrente M, S\u00e1nchez-Beato M, Gonz\u00e1lez-Rinc\u00f3n J, Royuela A, G\u00f3mez-Codina J, et al. Transformed follicular lymphoma in the rituximab era: a report from the Spanish Lymphoma Oncology Group. Hematol Oncol. 2019;37:143\u201350.","journal-title":"Hematol Oncol"},{"key":"3893_CR44","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.7754\/Clin.Lab.2021.211028","volume":"68","author":"C Sun","year":"2022","unstructured":"Sun C, Shen Z, Bian Z, Ma Y, Li J, Ma Y et al (2022) Disparity analysis of clinicopathologic hallmarks between transformed DLBCL and primary DLBCL. Clin Lab 68:1394\u20131401","journal-title":"Clin Lab"},{"issue":"14","key":"3893_CR45","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.3390\/ijms23147874","volume":"23","author":"B Uhl","year":"2022","unstructured":"Uhl B, Prochazka KT, Pansy K, Wenzl K, Strobl J, Baumgartner C, et al. Distinct chemokine receptor expression profiles in de novo DLBCL, transformed follicular lymphoma, Richter\u2019s trans-formed DLBCL and germinal center B-cells. Int J Mol Sci. 2022;23(14):7874.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3893_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/blood.2022018719","volume":"142","author":"K Dreval","year":"2023","unstructured":"Dreval K, Hilton LK, Cruz M, Shaalan H, Ben-Neriah S, Boyle M, et al. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns. Blood. 2023;142(6):561\u201373.","journal-title":"Blood"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03893-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:14:54Z","timestamp":1738113294000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03893-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3893"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03893-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with ethical guidelines (Declaration of Helsinki and Istanbul) and approved by the Institutional Ethics Committee of involved centers (IRB No. 2024\u20131010). Informed consent was waived due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}